These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34239372)

  • 21. Long-Term Prognosis of Alopecia Totalis and Alopecia Universalis: A Longitudinal Study with More than 10 Years of Follow-Up: Better than Reported.
    Jang YH; Hong NS; Moon SY; Eun DH; Lee WK; Chi SG; Kim JY; Lee WJ; Lee SJ; Kim DW
    Dermatology; 2017; 233(2-3):250-256. PubMed ID: 28704810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis.
    Colombe BW; Lou CD; Price VH
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):216-9. PubMed ID: 10674369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis.
    Setyawan J; Hodgkins P; Guérin A; Gauthier G; Cloutier M; Wu EQ; Erder MH
    J Med Econ; 2013 Jul; 16(7):962-75. PubMed ID: 23621503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulsed administration of corticosteroids in the treatment of alopecia areata.
    Sharma VK
    Int J Dermatol; 1996 Feb; 35(2):133-6. PubMed ID: 8850047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S; Kim BJ; Lee YB; Lee WS
    JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of total immunoglobulin e in patients with alopecia areata: relationship with clinical type of the disease.
    Kasumagić-Halilović E; Prohić A
    Acta Dermatovenerol Croat; 2006; 14(3):149-52. PubMed ID: 17010262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995-2016.
    Sørensen SBT; George P; Jagun O; Wolk R; Napatalung L; Zwillich SH; Iversen L; Ehrenstein V
    Dermatol Ther (Heidelb); 2024 Apr; 14(4):993-1006. PubMed ID: 38625633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of treatment for alopecia totalis and alopecia universalis.
    Kassira S; Korta DZ; Chapman LW; Dann F
    Int J Dermatol; 2017 Aug; 56(8):801-810. PubMed ID: 28378336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population.
    Kalkan G; Karakus N; Baş Y; Takçı Z; Ozuğuz P; Ateş O; Yigit S
    Gene; 2013 Sep; 527(2):565-9. PubMed ID: 23831512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exomic sequencing of immune-related genes reveals novel candidate variants associated with alopecia universalis.
    Lee S; Paik SH; Kim HJ; Ryu HH; Cha S; Jo SJ; Eun HC; Seo JS; Kim JI; Kwon OS
    PLoS One; 2013; 8(1):e53613. PubMed ID: 23326468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology.
    Taylor CR; Hawk JL
    Br J Dermatol; 1995 Dec; 133(6):914-8. PubMed ID: 8547044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.
    Mittal S; Boan AD; Kral MC; Lally MD; van Bakergem K; Macias MM; LaRosa A
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):81-86. PubMed ID: 31621385
    [No Abstract]   [Full Text] [Related]  

  • 33. PUVA treatment of alopecia areata totalis and universalis: a retrospective study.
    Whitmont KJ; Cooper AJ
    Australas J Dermatol; 2003 May; 44(2):106-9. PubMed ID: 12752182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a link between alopecia areata and gut?
    Hacınecipoğlu F; Gönül M; Özdemir Ş; Demir ÖF
    J Cosmet Dermatol; 2022 Nov; 21(11):6049-6055. PubMed ID: 35579378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.
    Liu LY; Craiglow BG; Dai F; King BA
    J Am Acad Dermatol; 2017 Jan; 76(1):22-28. PubMed ID: 27816293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of tofacitinib in treatment of alopecia universalis in two patients.
    Gupta AK; Carviel JL; Abramovits W
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1373-8. PubMed ID: 27306107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate for the treatment of pediatric alopecia areata.
    Landis ET; Pichardo-Geisinger RO
    J Dermatolog Treat; 2018 Mar; 29(2):145-148. PubMed ID: 28627278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All-Cause and Cause-Specific Mortality Risks Associated With Alopecia Areata: A Korean Nationwide Population-Based Study.
    Lee S; Lee YB; Kim BJ; Bae S; Lee WS
    JAMA Dermatol; 2019 Aug; 155(8):922-928. PubMed ID: 31141109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis.
    Mohan GC; Silverberg JI
    JAMA Dermatol; 2015 May; 151(5):522-8. PubMed ID: 25471826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.
    Eiland LS; Bell EA; Erramouspe J
    Ann Pharmacother; 2014 Oct; 48(10):1350-5. PubMed ID: 24982313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.